All Industries

Top Drug Discovery Companies

241 Drug Discovery companies, sorted by total funding raised.

241

Companies

$24.5B

Combined Funding

1

Funded (Last 60d)

Seed

Top Stage

Indexed tracks 241 Drug Discovery companies that have collectively raised $24.5B in documented funding. The most-funded drug discovery companies tracked include Asymchem and Abogen Biosciences. 1 company closed a new round in the last 60 days, with Seed being the most common funding stage.

AsymchemIPO

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Tianjin, China5001–10000Healthcare, Biotech
Private Equity·$2.3B·Feb 2020
Abogen Biosciences

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.

Suzhou, China201–500Biotech, mRNA Therapeutics
Extension Round·$1.3B·Nov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series D·$1.1B·Feb 2025
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech, Drug Discovery
Extension Round·$821.8M·Sep 2025
Enveda Biosciences

Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...

Boulder, United States201–500Artificial Intelligence, Biotech
Series D·$740.0M·Sep 2025
FogPharma

Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...

Cambridge, United States51–200Biotech, Drug Discovery
Series F·$694.0M·Jan 2025
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series B·$650.0M·Oct 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private Equity·$647.0M·Feb 2026
Alto Pharmacy

Digital full-service pharmacy offering prescription delivery, medication management, and speciali...

San Francisco, United States501–1000Drug Discovery, Healthcare
Venture Round·$620.0M·Sep 2023
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series B·$612.0M·Oct 2022
Relay TherapeuticsIPO

Clinical-stage precision medicines company using protein-motion-driven drug discovery to design s...

Cambridge, United States51–200Biotech, Drug Discovery
Series C·$520.0M·Dec 2018
GenentechIPO

Biotechnology company that discovers and develops medicines for serious, life-threatening disease...

San Francisco, United States10001+Biotech, Drug Discovery
Corporate Round·$492.3M·Feb 1990
Kallyope

Kallyope leverages unique insights into neural signaling pathways to develop innovative medicines...

New York, United States51–200Biotech, Drug Discovery
Grant·$487.2M·May 2023
RecursionIPO

AI-powered drug discovery and development company that uses biological and chemical datasets, mac...

Salt Lake City, United States501–1000Artificial Intelligence, Biotech
Corporate Round·$482.9M·Jul 2023
X4 PharmaceuticalsIPO

Clinical-stage biopharmaceutical company developing novel, oral medicines designed to treat a ran...

Boston, United States51–200Biotech, Drug Discovery
Series C·$446.8M·Oct 2025
Verve TherapeuticsAcquired

Develops one-time in vivo gene-editing medicines to prevent and treat atherosclerotic cardiovascu...

Boston, United States201–500Biotech, Drug Discovery
Series C·$428.5M·Oct 2024
Vividion TherapeuticsAcquired

Vividion Therapeutics is a Bayer-owned biopharmaceutical company using chemoproteomics-based drug...

San Diego, United States201–500Biotech, Drug Discovery
Series C·$368.0M·Feb 2021
Umoja

Develops in vivo CAR T cell therapies that generate CAR T cells inside patients to treat cancer.

Seattle, United States201–500Biotech, Drug Discovery
Series C·$363.0M·Jan 2025
Ventus Therapeutics

Clinical-stage biopharmaceutical company using structural biology and computational chemistry to ...

Montreal, Canada11–50Biotech, Drug Discovery
Grant·$360.1M·Apr 2023
Neuron23

Clinical-stage biotech developing precision medicines for genetically defined Parkinson’s disease...

South San Francisco, United States11–50Biotech, Drug Discovery
Series D·$310.0M·Jun 2025
Arbor Biotechnologies

Develops next-generation gene editing therapeutics for genetic diseases, advancing liver and CNS ...

Cambridge, United States51–200Biotech, Drug Discovery
Series C·$304.5M·Mar 2025
LifeMine Therapeutics

Clinical-stage biopharma mining fungal genomes to discover genetically-encoded small molecules fo...

Cambridge, United States51–200Biotech, Drug Discovery
Venture Round·$300.0M·Jan 2025
Cellarity

AI-powered multi-omics drug discovery platform targeting cell state regulation to restore proper ...

Somerville, United States51–200Artificial Intelligence, Biotech
Series C·$294.0M·Oct 2022
AbSciIPO

Generative AI drug creation platform for designing and developing biologics

Vancouver, United States201–500Artificial Intelligence, Biotech
Growth Equity·$279.5M·Aug 2025
BenchSci

AI-powered platform that accelerates drug discovery by helping pharmaceutical researchers find th...

Toronto, Canada201–500Artificial Intelligence, Drug Discovery
Series D·$265.2M·May 2023

Frequently Asked Questions

How many Drug Discovery companies are tracked on Indexed?

Indexed tracks 241 Drug Discovery companies, sorted by total funding raised.

How much funding have Drug Discovery companies raised in total?

The Drug Discovery companies tracked by Indexed have collectively raised $24.5B in documented funding.

What are the top-funded Drug Discovery companies?

The most-funded Drug Discovery companies tracked include Asymchem, Abogen Biosciences, Eikon Therapeutics.

Who are the top investors in Drug Discovery?

Leading investors active in Drug Discovery include Amplify Partners, EcoR1 Capital, Novartis Venture Fund.

Explore More

Other Industries